The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Editorial
Introduction
The EuroIntervention coronary bifurcation treatment supplement
May 19, 2015 | 10.4244/EIJV11SVA2
The basics
Anatomy and function relation in the coronary tree: from bifurcations to myocardial flow and mass
May 19, 2015 | 10.4244/EIJV11SVA3
Definitions and classifications of bifurcation lesions and treatment
May 19, 2015 | 10.4244/EIJV11SVA5
Lessons from the real bench: non-BRS
May 19, 2015 | 10.4244/EIJV11SVA6
Virtual bench testing to study coronary bifurcation stenting
May 19, 2015 | 10.4244/EIJV11SVA7
Coronary bifurcations as you have never seen them: the Visible Heart® Laboratory bifurcation programme
May 19, 2015 | 10.4244/EIJV11SVA9
Image-based assessment of fractional flow reserve
May 19, 2015 | 10.4244/EIJV11SVA11
IVUS in bifurcation stenting: what have we learned?
May 19, 2015 | 10.4244/EIJV11SVA12
Coronary fractional flow reserve in bifurcation stenoses: what have we learned?
May 19, 2015 | 10.4244/EIJV11SVA13
OCT for bifurcation stenting: what have we learned?
May 19, 2015 | 10.4244/EIJV11SVA14
New implication of three-dimensional optical coherence tomography in optimising bifurcation PCI
May 19, 2015 | 10.4244/EIJV11SVA15
The story of plaque shift and carina shift
May 19, 2015 | 10.4244/EIJV11SVA16
The story of side branch predilatation before provisional stenting
May 19, 2015 | 10.4244/EIJV11SVA17
Final kissing balloon inflation: the whole story
May 19, 2015 | 10.4244/EIJV11SVA18
Technical aspects
Technical aspects of the provisional side branch stenting strategy
May 19, 2015 | 10.4244/EIJV11SVA19
Technical aspects of the T And small Protrusion (TAP) technique
May 19, 2015 | 10.4244/EIJV11SVA20
When is a two-stent technique needed and which technique should then be used for bifurcation coronary lesions?
May 19, 2015 | 10.4244/EIJV11SVA21
Technical aspects of the culotte technique
May 19, 2015 | 10.4244/EIJV11SVA22
How to treat the left main
Differences between the left main and other bifurcations
May 19, 2015 | 10.4244/EIJV11SVA24
CABG, stents, or hybrid procedures for left main disease?
May 19, 2015 | 10.4244/EIJV11SVA25
The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation
May 19, 2015 | 10.4244/EIJV11SVA26
When and how to perform the provisional approach for distal LM stenting
May 19, 2015 | 10.4244/EIJV11SVA27
Which technique for double stenting in unprotected left main bifurcation coronary lesions?
May 19, 2015 | 10.4244/EIJV11SVA28
Dedicated stents for distal left main stenting
May 19, 2015 | 10.4244/EIJV11SVA29
Bioresorbable vascular scaffolds in left main coronary artery disease
May 19, 2015 | 10.4244/EIJV11SVA30
Why I like this dedicated stent?
Is there a need for dedicated devices?
May 19, 2015 | 10.4244/EIJV11SVA31
The Tryton Side Branch Stent
May 19, 2015 | 10.4244/EIJV11SVA33
The ABS mother-daughter platforms
May 19, 2015 | 10.4244/EIJV11SVA36
BRS in bifurcation lesions
Technology limitations of BRS in bifurcations
May 19, 2015 | 10.4244/EIJV11SVA38
Pathological aspects of bioresorbable stent implantation
May 19, 2015 | 10.4244/EIJV11SVA39
Bioresorbable scaffolds on the bench
May 19, 2015 | 10.4244/EIJV11SVA40
Lessons from the GHOST-EU registry
May 19, 2015 | 10.4244/EIJV11SVA41
Treatment of bioresorbable scaffold failure
May 19, 2015 | 10.4244/EIJV11SVA42
What about the risk of thrombosis with bioresorbable scaffolds?
May 19, 2015 | 10.4244/EIJV11SVA43
The future of BRS in bifurcations
May 19, 2015 | 10.4244/EIJV11SVA45